Related Experiment Video
Updated: Jun 14, 2025

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
Effect of recombinant human parathyroid hormone and zoledronic acid on osteoblast gene expression using multifaceted
Vandana Dhiman1, Sanjay Kumar Bhadada1, Poonam Kanta2
1Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Background:
Bone is an endocrine organ that despite being inert in appearance constantly undergoes remodeling, in which wear and tear of bone cells occur. With more than two decades of clinical experience, the molecular mechanisms of anti-fracture drugs are not completely understood because they inhibit osteoclastic activity and differentiate the osteoblast cells. Recent studies suggest fundamentally different mechanisms of action for key anti-fracture drugs, bisphosphonates, and recombinant human parathyroid hormone (rhPTH) at the tissue level; however, their molecular basis of action has not been explored completely. Here, we showed the effect of varying concentrations of zoledronic acid (ZOL) and rhPTH on human osteogenic sarcoma cells (U2OS cells).
Materials And Methods:
Cellular viability, mineralization, and osteogenic gene expressions were assessed to elucidate the effects of these two prototypic drugs with diametrically different mechanisms of action.
Results:
Cellular viability was not affected either by ZOL or rhPTH alone or in tandem treatments. Osteoblastic activity increased significantly with rhPTH followed by ZOL. Further, alkaline phosphatase activity increased significantly with tandem treatment of rhPTH followed by ZOL both at the mRNA and protein levels. Moreover, osteoblastic genes (COL1A1 and osteocalcin) were significantly modulated by sequential treatment with rhPTH followed by ZOL.
Conclusions:
We conclude that rhPTH (5 μg) treatment followed by ZOL (1 μM) showed the best anabolic or bone-forming effect. Our results warrant further research in assessing similar combinations of anti-fracture drugs, which augment osteogenesis to maximize their anabolic effects in preventing osteoporosis in susceptible individuals.
Insights
Recombinant human parathyroid hormone (rhPTH) followed by zoledronic acid (ZOL) demonstrated the most effective bone-forming activity. This sequential treatment enhances osteogenesis, offering potential for improved osteoporosis prevention.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Bone remodeling is a continuous process involving bone cell turnover.
- The precise molecular mechanisms of anti-fracture drugs like bisphosphonates and recombinant human parathyroid hormone (rhPTH) remain incompletely understood.
- This study investigates the effects of zoledronic acid (ZOL) and rhPTH on human osteogenic sarcoma cells (U2OS).
Purpose of the Study:
- To elucidate the molecular mechanisms of action for ZOL and rhPTH.
- To assess the combined effects of ZOL and rhPTH on osteogenesis.
- To identify optimal drug sequencing for maximizing anabolic bone effects.
Main Methods:
- Assessed cellular viability, mineralization, and osteogenic gene expression.
- Treated U2OS cells with varying concentrations of ZOL and rhPTH, both individually and sequentially.
- Analyzed alkaline phosphatase activity, COL1A1, and osteocalcin gene expression.
Main Results:
- Neither ZOL nor rhPTH affected cellular viability.
- Sequential treatment of rhPTH followed by ZOL significantly increased osteoblastic activity and alkaline phosphatase levels.
- Osteoblastic genes COL1A1 and osteocalcin were significantly modulated by the rhPTH-ZOL sequential treatment.
Conclusions:
- Sequential administration of rhPTH (5 μg) followed by ZOL (1 μM) yielded the most significant anabolic (bone-forming) effect.
- These findings suggest that combining anti-fracture drugs in a specific sequence can augment osteogenesis.
- Further research is warranted to explore similar drug combinations for enhanced osteoporosis prevention.
More Related Videos
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Osteoclasts in Bone Remodeling
Bone Remodeling
Skeleton and Calcium Homeostasis

